A detailed history of Bank Of Montreal transactions in Merus N.V. stock. As of the latest transaction made, Bank Of Montreal holds 13,335 shares of MRUS stock, worth $576,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,335
Holding current value
$576,205
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$39.01 - $49.16 $520,198 - $655,548
13,335 New
13,335 $561,000
Q2 2022

Aug 11, 2022

SELL
$13.98 - $29.25 $204,709 - $428,307
-14,643 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$23.58 - $30.91 $345,281 - $452,615
14,643 New
14,643 $403,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.98B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.